Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950109-02-004270
Filing Date
2002-08-14
Accepted
2002-08-14 16:06:46
Documents
7
Period of Report
2002-06-30

Document Format Files

Seq Description Document Type Size
1 PERIOD ENDING JUNE 30, 2002 d10q.htm 10-Q 316239
3 CONVERTIBLE DEBENTURE PURCHASE AGREEMENT dex10112.htm EX-10.112 97517
4 EMPLOYMENT AGREEMENT dex10113.htm EX-10.113 30072
5 AMENDMENT TO NON-EXCLUSIVE PATENT & LICENSE AGMT. dex10114.htm EX-10.114 31961
6 CERTIFICATION PURSUANT TO 18 U.S.C SECTION 1350 dex991.htm EX-99.1 2937
7 CERTIFICATION PURSUANT TO 18 U.S.C SECTION 1350 dex992.htm EX-99.2 3354
8 CERTIFICATION PURSUANT TO 18 U.S.C SECTION 1350 dex993.htm EX-99.3 2994
  Complete submission text file 0000950109-02-004270.txt   487414
Mailing Address 1265 HARBOR BAY PKWY ALAMEDA CA 94502
Business Address 1265 HARBOR BAY PARKWAY ALAMEDA CA 94502- 5107495100
CALYPTE BIOMEDICAL CORP (Filer) CIK: 0000899426 (see all company filings)

EIN.: 061226727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20985 | Film No.: 02736575
SIC: 3826 Laboratory Analytical Instruments